Table 1:

Characteristics of population with hypertension, diabetic nephropathy or heart failure, overall and among those dispensed combination angiotensin-converting-enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs)*

CharacteristicNo. (%) of patients
Overall
n = 1 104 593
Combination ACE inhibitors and ARBs
n = 51 327
Age, yr
 ≥ 65566 755 (51.3)29 489 (57.5)
 < 65537 838 (48.7)21 838 (42.6)
Sex
 Female553 882 (50.1)26 971 (52.6)
 Male550 387 (49.8)24 345 (47.4)
 Unknown324 (0.03)11 (0.02)
Hypertension
 Any856 705 (77.6)47 660 (92.9)
 Essential hypertension853 491 (77.3)47 556 (92.7)
 Hypertensive heart disease5765 (0.5)451 (0.9)
 Hypertensive kidney disease5568 (0.5)595 (1.2)
 Hypertensive heart and kidney disease1013 (0.1)104 (0.2)
 Secondary hypertension1256 (0.1)98 (0.2)
Heart failure143 104 (13.0)9739 (19.0)
Diabetic nephropathy556 545 (50.4)26 062 (50.8)
  • * Patients could have more than 1 condition.